Agitation and delirium are common occurrences in patients in intensive care units. The associated symptoms are marked by acute cerebral insufficiency arising out of structural and/or physiological abnormalities.
Agitation and delirium are common occurrences in patients in intensive care units (ICUs). The associated symptoms are marked by acute cerebral insufficiency arising out of structural and/or physiological abnormalities. Delirium is often cause of higher mortality and morbidity than non-delirious patients in all hospital settings. Delirium, a complex neuropsychiatric syndrome, is not just few symptoms but is a group of symptoms that are characterized by impaired consciousness, memory, orientation, thought, behavior, and perception. The prognosis of agitated and delirious in patients is usually low, mainly due to the fact that they are underdiagnosed in intensive care unit settings.
The study on the agitation in the delirium management market presents a detailed assessment of key growth dynamics, emerging forces of competition with focus on strategic frameworks relevant to the post-pandemic world, and projected opportunities in various segments by the end of the forecast period of 2020 – 2030.
Some of the key product categories in the agitation in the delirium management market include first-generation antipsychotics, second-generation antipsychotics, and benzodiazepines. Key distribution channels are retail pharmacies, online pharmacies, and hospital pharmacies.
Get Brochure of the Report @ https://www.tmrresearch.com/sample/sample?flag=B&rep_id=7488
Agitation in Delirium Management Market: Key Trends
Advances made in etiology, epidemiology, and pathophysiology have expanded the options for treatment, which have propelled the strides the agitation in the delirium management market market has made over the past several years.
Some of the first-line agents used for excited agitation in adults are antipsychotic including haloperidol, risperidone, and olanzapine, along with a benzodiazepine such as midazolam or lorazepam. Growing research on motor-defined clinical subtypes of delirium has enriched the landscape of the global market.
The high prevalence of delirium in elderly inpatients and in those on ICUs are key to demand for precise approaches in the agitation in delirium management. In the former, the number is 50%, while in the latter; it can be as high as 60 – 80%. The high hospitalization period due to inadequate management of agitation in delirium patients further complicates the matter: rise in costs of hospital stays and higher risk of death are major concerns. According to some of the studies mentioned in a recent articles in the NCBI, males, those in 30s represent the most challenging scenario for surgeons and clinicians. This has spurred the demand for new approaches to stabilization.
Agitation in Delirium Management Market: Competitive Dynamics and Key Developments
Some of the prominent players in the agitation in the delirium management market are
- BioXcel Therapeutics, Inc.
- Pfizer, Inc.
- Zydus Cadila,
- Akorn Incorporated
- Novartis International AG
- Fresenius Kabi AG
- Mylan N.V.
- Glenmark Pharmaceuticals Limited
- Sun Pharmaceutical Industries Ltd.
Players are increasingly leaning on offering efficacious pharmacological agents as well are keen on adhering to non-pharmacological treatment for ICU patients. Top companies are emphasizing the need for improving the diagnostics and radiological technologies and the associated medical infrastructure. Top players are keenly working to get pediatric medications approved by various global regulatory agencies.
Get Table of Content of the Report @ https://www.tmrresearch.com/sample/sample?flag=T&rep_id=7488
Agitation in Delirium Management Market: Regional Assessment
On the regional front, North America has been a highly promising regional market, presenting companies with vast revenue prospects. The adoption of tailored approach to different set of patients such as pediatrics and geriatrics is key to propelling strides of the regional market during the forecast period. Regular updates the guidelines have also helped bolster the prospects of market in the U.S., a key market in North America. American College of Gynecology (ACOG) and the adoption of protocols by the American College of Emergency Physicians are notable case in point.
About TMR Research
TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.
Contact:
Rohit Bhisey
TMR Research,
3739 Balboa St # 1097,
San Francisco, CA 94121
United States
Tel: +1-415-520-1050
Visit Site: https://www.tmrresearch.com/